Form 4: Lemaitre Vascular Director Sells 3,000 Shares

Director John James O'Connor sold 3,000 shares of Lemaitre Vascular stock on November 15, 2024.

Summary

• John James O'Connor, a director at Lemaitre Vascular, sold 3,000 shares of common stock on November 15, 2024.
• The sale was executed at a price of $0 per share, which likely indicates a transfer or gift rather than a market sale.
• Following the transaction, O'Connor directly owns 49,163 shares of Lemaitre Vascular.

Sentiment

Score: 5

Explanation: The document is a routine SEC Form 4 filing for an insider transaction. The $0 price suggests a transfer or gift, not a market sale, so it is neither positive nor negative.

Risks

• While this transaction appears to be a transfer or gift, any significant insider selling could be perceived negatively by the market.

Industry Context

Insider transactions are a normal part of corporate activity, but are closely watched by investors for signals about management's view of the company's prospects.

Comparison to Industry Standards

• It is common for directors to have stock transactions, but the $0 price is unusual and suggests a transfer or gift rather than a market sale.
• Other companies in the medical device sector also have directors who buy and sell shares, but the details of those transactions vary widely.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on stakeholders, as it appears to be a transfer or gift rather than a market sale.

Key Dates

Keywords

Lemaitre Vascular, insider trading, stock sale, director, John James O'Connor, LMAT